+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transdermal Patches Market - Global Forecast 2025-2030- Product Image
Transdermal Patches Market - Global Forecast 2025-2030- Product Image
Sale

Transdermal Patches Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5519528
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The transdermal patches market is evolving rapidly, enabling healthcare providers and manufacturers to deliver therapies more efficiently and enhance patient compliance. As stakeholders seek next-generation solutions for drug delivery, transdermal technologies are increasingly integral across chronic disease management, pain relief, and personalized therapeutics.

Market Snapshot: Transdermal Patches Market Overview

The global transdermal patches market grew from USD 7.95 billion in 2024 to USD 8.34 billion in 2025, with projections indicating continued expansion at a CAGR of 5.16% and a forecast value of USD 10.75 billion by 2030. This robust trajectory is fueled by rising demand for non-invasive, patient-centric drug delivery systems, ongoing innovation in patch design, and increasing prevalence of chronic health conditions requiring consistent medication adherence. Healthcare providers and product developers are capitalizing on advancements in material science and digital health integration, prompting strong competition and sustained investment.

Scope & Segmentation

This report delivers a comprehensive analysis across the market’s core segments, technology categories, and regional performance trends.

  • Product Types: Drug-in-adhesive, matrix, and micro-reservoir patch systems, including variations by single-layer and multi-layer constructs.
  • Active Ingredients: Buprenorphine, clonidine, fentanyl, lidocaine, nicotine, as well as specialized compounds for targeted indications.
  • Delivery Systems: Controlled and direct release modalities optimized for extended or rapid therapeutic effect.
  • Applications: Cardiovascular disorders, hormone replacement therapy, neurological conditions, pain management, smoking cessation, and wound management.
  • End Users: Ambulatory surgical centers, homecare settings, hospitals and clinics, research and academic institutes.
  • Layer Types: Multi-layer and single-layer configurations designed for dose modulation, durability, and patient comfort.
  • Geographic Coverage: Detailed market data for the Americas (including US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and key emerging economies), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Leading Companies: Inclusive of major pharmaceutical and device firms such as AbbVie, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Novartis, and regional manufacturers driving innovation.

Key Takeaways

  • Transdermal patches are at the forefront of patient-centric drug delivery, appealing to organizations seeking alternatives to oral and injectable formats to support adherence and minimize side effects.
  • New material and adhesive chemistries, including microneedles and biodegradable polymers, are expanding the therapeutic range and usability of these systems for a wider array of conditions.
  • Integration with digital health, such as sensor-enabled patches for monitoring adherence and treatment efficacy, is transforming how therapies are managed and optimized remotely.
  • Collaborative innovation among pharmaceutical firms, academic institutions, and contract manufacturers is accelerating the introduction and regulatory approval of novel products, reducing time-to-market for new therapies.
  • Sustainability initiatives—such as solvent-free production and recyclability—are increasingly woven into corporate strategies in response to evolving environmental standards.

Tariff Impact on Global Supply Chains

The 2025 release of new US tariffs has altered sourcing and logistics for critical patch components, affecting raw material access and manufacturing overheads. Industry players are building regional supply networks, shifting procurement strategies, and investing in local polymer synthesis to manage volatility and ensure compliance with updated trade requirements.

Methodology & Data Sources

Research findings are based on primary interviews with senior executives, clinicians, and regulatory experts, as well as surveys capturing operational realities on adherence and product performance. Secondary analysis of peer-reviewed journals, financial disclosures, and relevant industry frameworks—including SWOT and supply chain risk models—ensures accuracy and breadth.

Why This Report Matters

  • Enables leaders to assess precise growth opportunities and risk factors across product, technology, and region—including strategic shifts responding to tariffs and supply chain trends.
  • Informs portfolio development by mapping innovation and competitor strategies for transdermal patch design, digital integration, and sustainable manufacturing.
  • Supports investment and go-to-market decisions with evidence-based segmentation and actionable insights into global and local regulatory environments.

Conclusion

The transdermal patches market continues to advance through material innovations, digital connectivity, and targeted expansion strategies. Forward-thinking organizations that align investments with regional priorities and sustainability goals will benefit from evolving market conditions and emerging therapeutic needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in microneedle array transdermal systems enabling greater drug permeation and patient compliance
5.2. Integration of smart wearable sensors into transdermal patches for continuous drug release monitoring
5.3. Rising adoption of biodegradable polymer matrix patches to minimize residual medical waste generation
5.4. Emerging transdermal vaccine platforms utilizing novel adjuvants for targeted immune response enhancement
5.5. Development of long-acting opioid transdermal systems with built-in abuse deterrents and safety controls
5.6. Growth of personalized transdermal drug delivery programs using pharmacokinetic modeling for dose optimization
5.7. Introduction of dual-layer reservoir patches for simultaneous multi-drug administration and controlled kinetics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transdermal Patches Market, by Product Type
8.1. Introduction
8.2. Drug-In-Adhesive Patches
8.2.1. Multi-Layer Drug-In-Adhesive Patches
8.2.2. Single-Layer Drug-In-Adhesive Patches
8.3. Matrix Patches
8.3.1. Multi-Layer Matrix
8.3.2. Single-Layer Matrix
8.4. Micro-Reservoir Patches
9. Transdermal Patches Market, by Active Ingredient
9.1. Introduction
9.2. Buprenorphine
9.3. Clonidine
9.4. Fentanyl
9.5. Lidocaine
9.6. Nicotine
10. Transdermal Patches Market, by Delivery System
10.1. Introduction
10.2. Controlled Release
10.3. Direct Release
11. Transdermal Patches Market, by Application
11.1. Introduction
11.2. Cardiovascular Disorders
11.2.1. Clonidine Patches
11.2.2. Isosorbide Dinitrate Patches
11.3. Hormone Replacement Therapy
11.3.1. Combination Hormone Patches
11.3.2. Estrogen Patches
11.3.3. Progestin Patches
11.4. Neurological Conditions
11.5. Pain Management
11.5.1. Diclofenac-Based
11.5.2. Fentanyl-Based
11.5.3. Lidocaine-Based
11.6. Smoking Cessation
11.7. Wound Management
12. Transdermal Patches Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Homecare Settings
12.4. Hospitals & Clinics
12.5. Research & Academic Institutes
13. Transdermal Patches Market, by Layer Type
13.1. Introduction
13.2. Multi-Layer
13.3. Single Layer
14. Americas Transdermal Patches Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Transdermal Patches Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Transdermal Patches Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. AdhexPharma SAS
17.3.3. Amneal Pharmaceuticals, Inc.
17.3.4. Bayer AG
17.3.5. BioNxt Solutions Inc.
17.3.6. Bliss GVS Pharma Ltd.
17.3.7. Boehringer Ingelheim International GmbH
17.3.8. Corium, Inc.
17.3.9. Corsair Pharma, Inc.
17.3.10. DifGen Pharmaceuticals LLC
17.3.11. Endo International plc
17.3.12. Gedeon Richter Plc
17.3.13. GlaxoSmithKline Plc
17.3.14. Icure Pharmaceutical Inc.
17.3.15. Johnson & Johnson Services, Inc.
17.3.16. LAVIPHARM GROUP HOLDING S.A.
17.3.17. Lohmann Therapie-Systeme AG
17.3.18. Luye Pharma Group Ltd
17.3.19. Medherant Limited
17.3.20. Nitto Denko Corporation
17.3.21. Novartis AG
17.3.22. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
17.3.23. Nutriband Inc
17.3.24. Perrigo Company plc
17.3.25. ProSolus, Inc.
17.3.26. Purdue Pharma L.P.
17.3.27. Sparsha Pharma International Pvt Ltd
17.3.28. Teikoku Seiyaku Co., Ltd.
17.3.29. Teva Pharmaceutical Industries Ltd.
17.3.30. Viatris Inc.
17.3.31. Zydus Group
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TRANSDERMAL PATCHES MARKET: RESEARCHAI
FIGURE 28. TRANSDERMAL PATCHES MARKET: RESEARCHSTATISTICS
FIGURE 29. TRANSDERMAL PATCHES MARKET: RESEARCHCONTACTS
FIGURE 30. TRANSDERMAL PATCHES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 150. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 151. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 152. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 153. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 154. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 155. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 156. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 157. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 160. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 161. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 162. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 163. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 164. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 165. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 176. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 177. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 178. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 179. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 184. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 185. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 186. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 187. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 288. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 289. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 290. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 291. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 296. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 297. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 298. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 299. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2024 (USD MILLION)
TABLE 306. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2025-2030 (USD MILLION)
TABLE 307. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2024 (USD MILLION)
TABLE 308. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2025-2030 (USD MILLION)
TABLE 309. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 310. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 311. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 312. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 313. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 318. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 319. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 320. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 321. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2024 (USD MILLION)
TABLE 324. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025-2030 (USD MILLION)
TABLE 325. RUS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Transdermal Patches market report include:
  • AbbVie Inc.
  • AdhexPharma SAS
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioNxt Solutions Inc.
  • Bliss GVS Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • Corsair Pharma, Inc.
  • DifGen Pharmaceuticals LLC
  • Endo International plc
  • Gedeon Richter Plc
  • GlaxoSmithKline Plc
  • Icure Pharmaceutical Inc.
  • Johnson & Johnson Services, Inc.
  • LAVIPHARM GROUP HOLDING S.A.
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Medherant Limited
  • Nitto Denko Corporation
  • Novartis AG
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
  • Nutriband Inc
  • Perrigo Company plc
  • ProSolus, Inc.
  • Purdue Pharma L.P.
  • Sparsha Pharma International Pvt Ltd
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Group

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.34 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.75 Billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Hormonal Transdermal Patches Market - Global Forecast 2025-2030 - Product Image

Hormonal Transdermal Patches Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Transdermal Drug Delivery System Market - Global Forecast 2025-2030 - Product Image

Transdermal Drug Delivery System Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2025-2033 - Product Image

Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2025-2033

  • Report
  • 125 Pages
  • Global
From
Biostimulants Market by Active Ingredients (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode of Application (Foliar treatment, Soil treatment, Seed treatment), Form, and Region - Global Forecast to 2030 - Product Image

Biostimulants Market by Active Ingredients (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode of Application (Foliar treatment, Soil treatment, Seed treatment), Form, and Region - Global Forecast to 2030

  • Report
  • 318 Pages
  • Global
From
Active Ingredients - Global Strategic Business Report - Product Image

Active Ingredients - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.